Thank you, Bob, and good morning, everyone. As Rob mentioned, we are pleased to report our third consecutive quarter of strong sequential and year-over-year revenue growth for the fourth quarter. We saw significant growth in all our markets and channels for both the quarter and the full fiscal year. Before getting into the comparisons and getting into more detail of our fourth quarter and our full fiscal year results, I do want to note that our fourth quarter results is in a more normalized state as there is no impact from the Paycheck Protection Program, loan forgiveness, and no impact from the employee retention tax credits. And looking at the four fiscal year results, there will be impact from both the PPP loan forgiveness and the ERC as we recognize those impacts in the second and third quarter of fiscal 2021. For comparison purposes here as I go through our results, I will be excluding the impact of the PPP loan forgiveness and the ERC where applicable to make the results more comparable. Sales in the fourth quarter were at $21.1 million, up 38% sequentially from Q3 and up 97% year-over-year. For the full fiscal year, sales increased 33% year-over-year to $57.4 million. With our increase in sales, comparisons of our fourth quarter results to the prior quarter were all favorable whether looking at net income, EPS or adjusted EBITDA. Gross profit margin was 25.3% compared to 27.8% in the preceding third quarter. And as Rob noted, the decrease in our margin was driven by the concentrated Tier-1 business and the impact of the current state of the supply chain and material and shipping costs. This was not unexpected given our hybrid fiber solution has been such a large piece of our backlog, which means we had locked in pricing with our customer for these large orders and margins was impacted by the rising costs of shipping and certain materials as a result of the widely reported supply chain issues. We do expect to see the impact of the supply chain and increased cost to continue, but do anticipate it to moderate as the year progresses. To offset these rising costs, we are actively monitoring our pricing and making changes where necessary to address the increased costs we are experiencing. Further, we do see room to improve our margins through improved product mix, which includes large opportunities that we have in our pipeline related to our higher margins, small cell and DAC offerings. Even with the margin impact, a significant amount of this revenue fell to the bottom line. Operating income was $1.1 million, up from operating income of $393,000 in the preceding third quarter. On the bottom line, we generated fourth quarter net income of $813,000 or $0.08 per diluted share and non-GAAP net income of $1.1 million or $0.10 per diluted share. Both of which were up significantly on a year-over-year basis. Adjusted EBITDA was $1.5 million, up 47% from $1 million in the preceding third quarter. In our fourth quarter results, we also included a one time acquisition related charges of $105,000 and we also recognized sales and performance related expenses and bonuses of $595,000. Following the close of the quarter, we filed S-3 shelf registration statement for the potential sale of up to $100 million in our common stock, debt securities or warrants. The shelf is intended to give the company flexibility to take advantage of our financing opportunities in the future, to fund general corporate purposes or future acquisitions, and is effective for three years. In regard to our pending acquisition of Microlab announced last week, we intend to pay the purchase price through a combination of cash on hand and borrowing from a bank facility. We do not plan to use the shelf to finance this acquisition. Our balance sheet remains strong and included cash and cash equivalent of $13 million and working capital of $31.3 million at the end of the quarter, compared to the preceding third quarter, cash was up slightly by $475,000 and accounts receivable increased by $2.9 million as well. The cash volunteer does not yet include a portion of the ERC credit. The remaining receivables related to the ERC is included as part of our other current assets, which is $1.7 million and we expect to receive in the first half of the calendar year. Moving on, we continue to see momentum build around new business, as evidenced by our improved bookings and growth in our backlog. Backlog was $33.3 million at October 31, 2021 and fourth quarter bookings of $22.9 million. As of today, our backlog currently stands at $30.5 million. Looking ahead, given the first quarter is seasonally our toughest quarter, we expect revenue to come down a bit compared to the fourth quarter, but certainly up significantly over last year's Q1. And looking to the coming fiscal year, as Rob mentioned, we expect year-over-year revenue growth to be north of 10%, which will put our total fiscal 2022 sales to at least $63 million. This growth rate does not include any Microlab revenue, or any additional significant hybrid fiber orders. These will be upside to that number as well. This concludes my discussion. Operator, we're ready to take our first question.